Lot No: 1.1
II.2.1) Title
BORTEZOMIB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.10
II.2.1) Title
EPIRUBICIN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.11
II.2.1) Title
FLUOROURACIL
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.12
II.2.1) Title
GANCICLOVIR
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.13
II.2.1) Title
GEMCITABINE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.14
II.2.1) Title
INFLIXIMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.15
II.2.1) Title
IRINOTECAN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.16
II.2.1) Title
METHOTREXATE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.17
II.2.1) Title
NIVOLUMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.18
II.2.1) Title
OXALIPLATIN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.19
II.2.1) Title
PACLITAXEL
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.2
II.2.1) Title
CARBOPLATIN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.20
II.2.1) Title
PEMBROLIZUMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.21
II.2.1) Title
PERTUZUMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.22
II.2.1) Title
RITUXIMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.23
II.2.1) Title
TRASTUZUMAB SC
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.24
II.2.1) Title
TRASTUZUMAB IV
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.25
II.2.1) Title
VINCRISTINE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.3
II.2.1) Title
CETUXIMAB
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.4
II.2.1) Title
CISPLATIN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.5
II.2.1) Title
CYCLOPHOSPHAMIDE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.6
II.2.1) Title
CYTARABINE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.7
II.2.1) Title
DESFERRIOXAMINE
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.8
II.2.1) Title
DOCETAXEL
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 1.9
II.2.1) Title
DOXORUBICIN
II.2.2) Additional CPV code(s)
33600000
33692000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Aseptically Prepared Dose Banded Medicines
II.2.2) Additional CPV code(s)
33600000
33680000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
CIVAS (Centralised Intravenous Additive Service)
II.2.2) Additional CPV code(s)
33600000
33680000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Patient Specific Chemotherapy
II.2.2) Additional CPV code(s)
33600000
33680000
85149000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 60%
Cost criterion: Price
/ Weighting: 40%
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Title: Lot 1- Aseptically Prepared Dose Banded Medicines Committed Spend - West Midlands Region
The contract has been awarded to a group of economic operators:
Yes
Title: Lot 2 - Aseptically Prepared Dose Banded Medicines – All Regions
The contract has been awarded to a group of economic operators:
Yes
Title: Lot 3 – CIVAS (Centralised Intravenous Additive Service) – All Regions
The contract has been awarded to a group of economic operators:
No